MedPath

Feasibility study of a non-contrast MRI-scan for breast cancer screening using Velocity Selective Arterial Spin Labeling

Phase 2
Completed
Conditions
breast cancer
10027656
10006232
Registration Number
NL-OMON50007
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

female patients scheduled for an MR-breast scan
patients volunteer to participate and are capable and prepared to sign an
informed consent
patients of 18 years or older.

Exclusion Criteria

patients who would otherwise not an undergo MR-breast scan
patients who are not able or willing to comply with breathing instructions
patients with contra-indications for Gadolinium-contrast agents
patients who underwent breast reduction.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>As the main study parameter VS-ASL and DCE-MRI scans will be compared on image<br /><br>quality based on visual scoring of three experienced radiologists. The readers<br /><br>will be blinded to original study interpretations. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>As secondary study parameter VS-ASL and DCE-MRI scans will be compared based on<br /><br>quantitative lesion characteristics, e.g. tumor size, relative signal<br /><br>enhancement of tumor, etc, as well as overall suspicion for cancer.<br /><br>In addition, VS-ASL and DCE-MRI outcome will be compared to biopsy results (if<br /><br>available).</p><br>
© Copyright 2025. All Rights Reserved by MedPath